← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Dtx Pharma, Llc
San Diego, CA
$1,548,730
Total funding
5
Grants
Funding over time
peak $847.8K · FY2019–21$1M$750K$500K$250K$0
'19
'20
'21
Funding mix
By agency
NIH$1,548,730 · 5
By mechanism
R43$1,235,765 · 4
R41$312,965 · 1
Investigators at Dtx Pharma, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of PMP22 siRNA Conjugates for Treatment of Charcot-Marie-Tooth Disease Type 1A$387,925
R43 · FY2020 · NS
Systemic Characterization of Novel Lipidated siRNA Conjugates$321,555
R43 · FY2019 · TR
Development of Conjugated Oligonucleotide Therapeutics for Neuronal Disease$301,212
R43 · FY2019 · TR
Generation of potent, safe and deliverable human Tau targeting siRNA for treatment of Tauopathies$225,073
R43 · FY2019 · AG
Reversal of Tau Pathology with MSUT2 siRNA Conjugates$213,027
R41 · FY2020 · AG
Reversal of Tau Pathology with MSUT2 siRNA Conjugates$99,938
R41 · FY2021 · AG